Viking Therapeutics (VKTX) Misses Q1 EPS by 1c

Viking Therapeutics (NASDAQ: VKTX) reported Q1 EPS of ($0.25), $0.01 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• B.Riley on Viking Therapeutic (VKTX): 'we continue to see an attractive setup'
• Chime to acquire Stride Bank for $590M in cash